Bristol-Myers Squibb Canada Co. et al. v Sandoz Canada Inc.

Call to arrange a consultation

2019

T-503-19

Resolved

New PM(NOC) Regulations

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,791,171 (apixaban)

Counsel to:

Sandoz Canada Inc.

The decision is reported

Counsel

Associate